BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33116311)

  • 1. Single-cell mutation analysis of clonal evolution in myeloid malignancies.
    Miles LA; Bowman RL; Merlinsky TR; Csete IS; Ooi AT; Durruthy-Durruthy R; Bowman M; Famulare C; Patel MA; Mendez P; Ainali C; Demaree B; Delley CL; Abate AR; Manivannan M; Sahu S; Goldberg AD; Bolton KL; Zehir A; Rampal R; Carroll MP; Meyer SE; Viny AD; Levine RL
    Nature; 2020 Nov; 587(7834):477-482. PubMed ID: 33116311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
    Stosch JM; Heumüller A; Niemöller C; Bleul S; Rothenberg-Thurley M; Riba J; Renz N; Szarc Vel Szic K; Pfeifer D; Follo M; Pahl HL; Zimmermann S; Duyster J; Wehrle J; Lübbert M; Metzeler KH; Claus R; Becker H
    Br J Haematol; 2018 Sep; 182(6):830-842. PubMed ID: 29974943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2
    Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L
    Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level.
    García-Sanz R; García-Álvarez M; Medina A; Askari E; González-Calle V; Casanova M; de la Torre-Loizaga I; Escalante-Barrigón F; Bastos-Boente M; Bárez A; Vidaña-Bedera N; Alonso JM; Sarasquete ME; González M; Chillón MC; Alcoceba M; Jiménez C
    Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37493341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms.
    Schaub FX; Looser R; Li S; Hao-Shen H; Lehmann T; Tichelli A; Skoda RC
    Blood; 2010 Mar; 115(10):2003-7. PubMed ID: 20061559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
    Hartmann L; Metzeler KH
    Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell analysis of clonal architecture in acute myeloid leukaemia.
    Potter N; Miraki-Moud F; Ermini L; Titley I; Vijayaraghavan G; Papaemmanuil E; Campbell P; Gribben J; Taussig D; Greaves M
    Leukemia; 2019 May; 33(5):1113-1123. PubMed ID: 30568172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis.
    Niemöller C; Renz N; Bleul S; Blagitko-Dorfs N; Greil C; Yoshida K; Pfeifer D; Follo M; Duyster J; Claus R; Ogawa S; Lübbert M; Becker H
    Leuk Res; 2016 Aug; 47():41-6. PubMed ID: 27244256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal hematopoiesis and risk of acute myeloid leukemia.
    Young AL; Tong RS; Birmann BM; Druley TE
    Haematologica; 2019 Dec; 104(12):2410-2417. PubMed ID: 31004019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping genotypes to chromatin accessibility profiles in single cells.
    Izzo F; Myers RM; Ganesan S; Mekerishvili L; Kottapalli S; Prieto T; Eton EO; Botella T; Dunbar AJ; Bowman RL; Sotelo J; Potenski C; Mimitou EP; Stahl M; El Ghaity-Beckley S; Arandela J; Raviram R; Choi DC; Hoffman R; Chaligné R; Abdel-Wahab O; Smibert P; Ghobrial IM; Scandura JM; Marcellino B; Levine RL; Landau DA
    Nature; 2024 May; 629(8014):1149-1157. PubMed ID: 38720070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
    Lundberg P; Karow A; Nienhold R; Looser R; Hao-Shen H; Nissen I; Girsberger S; Lehmann T; Passweg J; Stern M; Beisel C; Kralovics R; Skoda RC
    Blood; 2014 Apr; 123(14):2220-8. PubMed ID: 24478400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
    Sadigh S; Kim AS
    Clin Lab Med; 2024 Jun; 44(2):339-353. PubMed ID: 38821648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms.
    Hinze A; Rinke J; Crodel CC; Möbius S; Schäfer V; Heidel FH; Hochhaus A; Ernst T
    Br J Haematol; 2023 Jul; 202(2):308-317. PubMed ID: 37139709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
    Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
    Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
    Nam AS; Kim KT; Chaligne R; Izzo F; Ang C; Taylor J; Myers RM; Abu-Zeinah G; Brand R; Omans ND; Alonso A; Sheridan C; Mariani M; Dai X; Harrington E; Pastore A; Cubillos-Ruiz JR; Tam W; Hoffman R; Rabadan R; Scandura JM; Abdel-Wahab O; Smibert P; Landau DA
    Nature; 2019 Jul; 571(7765):355-360. PubMed ID: 31270458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective.
    Rontauroli S; Carretta C; Parenti S; Bertesi M; Manfredini R
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonal evolution of myeloid malignancies].
    Kon A
    Rinsho Ketsueki; 2020; 61(9):1120-1129. PubMed ID: 33162507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Grove CS; Vassiliou GS
    Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
    Prick J; de Haan G; Green AR; Kent DG
    Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.